Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 3MG;0.02MG | 0 | LORYNA | DROSPIRENONE; ETHINYL ESTRADIOL |
FDA Submissions
| ORIG | 1 | AP | 2011-03-28 | |
LABELING; Labeling | SUPPL | 4 | AP | 2012-09-19 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2020-04-28 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-04-28 | STANDARD |
LABELING; Labeling | SUPPL | 14 | AP | 2020-04-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 4 | Null | 15 |
SUPPL | 11 | Null | 7 |
SUPPL | 13 | Null | 7 |
SUPPL | 14 | Null | 15 |
TE Codes
CDER Filings
XIROMED
cder:Array
(
[0] => Array
(
[ApplNo] => 79221
[companyName] => XIROMED
[docInserts] => ["",""]
[products] => [{"drugName":"LORYNA","activeIngredients":"DROSPIRENONE; ETHINYL ESTRADIOL","strength":"3MG;0.02MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LORYNA","submission":"DROSPIRENONE; ETHINYL ESTRADIOL","actionType":"3MG;0.02MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)